OPTIDRUGS Overview
- Status
-
Private
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
1
OPTIDRUGS General Information
Description
Developer of clinical decision support software designed to optimize anti-infective drug dosing at the patient's bedside. The company's SaaS solution utilizes algorithms that integrate patient characteristics, drug properties, and pathogen data, enabling clinicians to predict and adjust optimal dosages for critical care and renal replacement therapies.
Contact Information
Corporate Office
- Paris
- France
Corporate Office
- Paris
- France
OPTIDRUGS Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Accelerator/Incubator | 01-Jan-2024 | Completed | Startup |
OPTIDRUGS Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Paris Biotech Sante | Accelerator/Incubator |
OPTIDRUGS FAQs
-
Where is OPTIDRUGS headquartered?
OPTIDRUGS is headquartered in Paris, France.
-
What industry is OPTIDRUGS in?
OPTIDRUGS’s primary industry is Decision/Risk Analysis.
-
Is OPTIDRUGS a private or public company?
OPTIDRUGS is a Private company.
-
What is OPTIDRUGS’s current revenue?
The current revenue for OPTIDRUGS is .
-
Who are OPTIDRUGS’s investors?
Paris Biotech Sante has invested in OPTIDRUGS.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process